儿童耐药性癫痫脑[18F]FDG-PET总辐射剂量的长期趋势
回顾性分析2005至2021年55例耐药性癫痫患儿共61次[18F]FDG-PET扫描,评估注射剂量、CT辐射剂量与图像质量随时间的变化。注射[18F]FDG剂量每年下降约1%,按体重给药活度无显著变化,CTDIvol与DLP分别每年下降16%和15%,PET图像质量每年提升9%。
要点
- 注射[18F]FDG剂量每年下降约1%(95%CI 0.92%-0.98%,p<0.001),按体重给药活度无显著变化(p=0.51)。
- CTDIvol每年下降16%(95%CI 9%-23%),DLP每年下降15%(95%CI 8%-21%),均p<0.001。
- PET图像质量每年提升9%(95%CI 6%-13%,p<0.001),CT相关SNR与CNR分别每年下降7%和6%。
核心结论
- 按体重给药的[18F]FDG活度保持稳定,PET图像质量改善,CT相关辐射剂量降低。
- 作者认为这些结果再次确认[18F]FDG-PET作为儿童耐药性癫痫辅助影像手段越来越安全且分辨率更高。
- 作者认为由技术进步驱动的这些改善可能提升儿童癫痫手术的诊断精度与患者结局。
研究设计与样本
- 回顾性分析2005至2021年间因术前评估接受[18F]FDG-PET/CT或磁共振扫描的耐药性癫痫患儿数据。
- 共纳入55例儿童(30例男性,平均年龄9±6岁),共61次[18F]FDG-PET扫描,其中71%为PET/CT。
- 评估注射[18F]FDG剂量、按体重给药活度、CT剂量指数容积(CTDIvol)与剂量长度乘积(DLP)的变化。
- PET图像质量由四名受过训练的评分者视觉评估;CT图像质量通过感兴趣区分析测量,并以信噪比(SNR)与对比噪声比(CNR)归一化。
主要发现
- 注射[18F]FDG剂量每年下降约1%(95%CI 0.92%-0.98%,p<0.001),按体重给药活度无显著变化(p=0.51)。
- CTDIvol每年下降16%(95%CI 9%-23%),DLP每年下降15%(95%CI 8%-21%),两者均p<0.001。
- PET图像质量每年提升9%(95%CI 6%-13%,p<0.001)。
- CT相关SNR每年下降7%(95%CI 3%-11%,p=0.001),CNR每年下降6%(95%CI 2%-10%,p=0.008)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the trends in administered 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) doses, computed tomography (CT) radiation doses, and image quality over the last 15 years in children with drug-resistant epilepsy (DRE) undergoing hybrid positron emission tomography (PET) brain scans. METHODS: We retrospectively analyzed data from children with DRE who had [18F]FDG-PET/CT or magnetic resonance scans for presurgical evaluation between 2005 and 2021. We evaluated changes in injected [18F]FDG doses, administered activity per body weight, CT dose index volume (CTDIvol), and dose length product (DLP). PET image quality was assessed visually by four trained raters. Conversely, CT image quality was measured using region-of-interest analysis, normalized by signal-to-noise (SNR) and contrast-to-noise ratio (CNR). RESULTS: We included 55 children (30 male, mean age: 9 ± 6 years) who underwent 61 [18F]FDG-PET scans (71% as PET/CT). Annually, the injected [18F]FDG dose decreased by ~ 1% (95% CI: 0.92%-0.98%, p < 0.001), with no significant changes in administered activity per body weight (p = 0.51). CTDIvol and DLP decreased annually by 16% (95% CI: 9%-23%) and 15% (95% CI: 8%-21%, both p < 0.001), respectively. PET image quality improved by 9% year-over-year (95% CI: 6%-13%, p < 0.001), while CT-associated SNR and CNR decreased annually by 7% (95% CI: 3%-11%, p = 0.001) and 6% (95% CI: 2%-10%, p = 0.008), respectively. CONCLUSION: Our findings indicate stability in [18F]FDG administered activity per body weight alongside improvements in PET image quality. Conversely, CT-associated radiation doses reduced. These results reaffirm [18F]FDG-PET as an increasingly safer and higher-resolution auxiliary imaging modality for children with DRE. These improvements, driven by technological advancements, may enhance the diagnostic precision and patient outcomes in pediatric epilepsy surgery.
引用
- Gennari AG, Waelti S, Schwyzer M, et al. Long-term trends in total administered radiation dose from brain [18F]FDG-PET in children with drug-resistant epilepsy. Eur J Nucl Med Mol Imaging. 2024. PMID: 39352423. doi:10.1007/s00259-024-06902-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。